Skip to main content
Premium Trial:

Request an Annual Quote

Immunetics MycoDx

Immunetics has launched the MycoDx assay, a multiplex molecular assay that can identify 21 fungal pathogens in a whole blood sample, including Candida, Aspergillus, Cryptococcus, Coccidioides, Fusarium and other species. Other fungal targets are also in development.

The new test — which Immunetics will offer through its US clinical reference laboratory service — does not require a culturing step, reducing assay turnaround time to about eight hours. The company said its development team is also working to transfer the assay into a user friendly microarray format for worldwide distribution.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.